https://www.biospace.com/press-releases/cassava-sciences-licenses-simufilam-method-of-treatment-patent
Cassava Sciences Licenses Simufilam Method of Treatment Patent - BioSpace
cassava scienceslicensessimufilammethodtreatment
https://kffhealthnews.org/morning-breakout/disappointing-cassava-sciences-ends-study-of-alzheimers-drug-simufilam/
'Disappointing': Cassava Sciences Ends Study Of Alzheimer's Drug Simufilam - KFF Health News
Nov 26, 2024 - The company's future now appears to be in flux, as simufilam was its only drug in clinical trials, The New York Times reported. Also: a Roche lung cancer drug...